GYRATE ATROPHY OF THE CHOROID AND RETINA AND OTHER RETINAL DEGENERATIONS
脉络膜和视网膜旋转萎缩以及其他视网膜变性
基本信息
- 批准号:3777604
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:arginine autosomal recessive trait congenital eye disorder diet therapy dietary aminoacid dietary proteins enzyme mechanism eye disorder chemotherapy eye disorder diagnosis heterozygote homozygote human subject human therapy evaluation nutrition related tag ornithine oxoacid transaminase ornithinemia pyridoxine retina degeneration retinitis pigmentosa tissue /cell culture
项目摘要
Patients with gyrate atrophy of the choroid and retina are examined
systematically to confirm the diagnosis. Skin fibroblasts from affected
patients and family members are grown in tissue culture and assayed for
ornithine aminotransferase activity. The results are evaluated for
correlation with the presence of homozygosity or heterozygosity for the
disease trait. Each patient is given a trial of pyridoxine to see whether
serum concentration of ornithine can be reduced; if so, the patient is
classified as a "responder" and treatment with pyridoxine is continued.
Nonresponder and responder patients are then placed on a low-arginine,
low-protein diet with supplemental amino acids and observed for arrest or
improvement of the disease. If patients are not considered eligible for
the diet, or if they appear unable to comply with the dietary regimen, we
follow them to record the natal progression of the condition. Patients
with other forms of retinal degeneration, such as retinitis pigmentosa,
fundus flavimaculatus, juvenile retinoschisis, and Usher's syndrome, also
are examined. The courses of their diseases are compared with those of
gyrate atrophy patients.
脉络膜和视网膜回旋状萎缩的患者进行检查
系统地确认诊断。受影响的皮肤成纤维细胞
患者和家庭成员在组织培养物中生长,
鸟氨酸氨基转移酶活性 评价结果,
与存在的纯合性或杂合性的相关性
疾病特征每个病人都要接受吡哆醇的试验,
可以降低血清中鸟胺酸的浓度;如果是这样,则患者
被归类为“应答者”,继续用吡哆醇治疗。
然后将无应答者和应答者患者置于低精氨酸,
补充氨基酸的低蛋白饮食,并观察是否停止,或
疾病的改善。如果患者被认为不适合
饮食,或者如果他们似乎无法遵守饮食养生法,我们
跟踪他们记录出生时的病情进展患者
对于其它形式的视网膜变性,例如色素性视网膜炎,
眼底黄斑、青少年视网膜劈裂和Usher综合征,也
进行检查。并将其病程与对照组进行比较。
回旋状萎缩患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M I KAISER-KUPFER其他文献
M I KAISER-KUPFER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M I KAISER-KUPFER', 18)}}的其他基金
GYRATE ATROPHY OF THE CHOROID AND RETINA AND OTHER RETINAL DEGENERATIONS
脉络膜和视网膜旋转萎缩以及其他视网膜变性
- 批准号:
2574477 - 财政年份:
- 资助金额:
-- - 项目类别:
A DOUBLE-MASKED CONTROLLED RANDOMIZED CLINICAL TRIAL OF TOPICAL CYSTEAMINE
外用半胱胺的双重对照随机临床试验
- 批准号:
3856038 - 财政年份:
- 资助金额:
-- - 项目类别:
NIH INTERINSTITUTE MEDICAL GENETICS PROGRAM--THE GENETICS CLINIC
NIH 研究所间医学遗传学项目--遗传学诊所
- 批准号:
3777619 - 财政年份:
- 资助金额:
-- - 项目类别:














{{item.name}}会员




